Monday, June 27,2005 @ 11:25am
Inforsense KDE, BioSense Grid available for Tiger
InforSense today announced the launch of its integrative analytics platform InforSense KDE on Mac OS X 10.4 "Tiger" and also announced InforSense BioSense Grid, the first service-based high-performance environment for creating and publishing bioinformatics applications, on an Xserve-based workgroup cluster. InforSense BioSense Grid integrates iNquiry, the cluster and web portal for bioinformatics from The BioTeam, with the visual workflow, analytics and web services-based architecture of InforSense KDE. The company is providing on-going demonstrations at ISMB 2005 (Detroit, MI) from June 26-29, highlighting the use of InforSense KDE and BioSense Grid, mapped to an Xserve G5 cluster, to create the first Service-Oriented environment for bioinformatics.
"BioSense Grid offers a unique environment for large scale bioinformatics," said Prof. Yike Guo, CEO and Founder of InforSense. "With the popularity of the Apple Mac platform among life sciences researchers, the high performance Tiger and Xserve G5 cluster was the obvious choice for our first BioSense Grid demonstration."
InforSense KDE, the company's flagship product, consists of a visual workflow environment for analytics integrating data sources, software applications and web services across research and business informatics; a workflow warehouse for capturing, managing and utilizing process knowledge and Intellectual Property (IP); and a powerful deployment engine to enable workflows for web-ready applications.
The company said that bioinformaticians can easily create tailored applications using the BioTeam's Grid services and also deploy to the iNquiry web portal as new services that are automatically mapped to the distributed computing environment. The environment features support complex, large-scale sequence analysis and annotation using the Xserve cluster as well as monitors cluster performance and manages analytic process execution using InforSense integrative analytics technology.
"Science and biotech researchers are increasingly choosing the power, stability and ease-of-use of Mac OS X and Xserve G5," said Ron Okamoto, Apple's vice president of Worldwide Developer Relations. "We're excited that InforSense has taken advantage of Apple innovation to give researchers rapid and reliable access to important data, tools and computational power."